Total Funding
60
39
Total FundingSeed raised
Growth Score 60 in past quarter
-5 pts
Heat Score 39 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
130282
Jengu Therapeutics is a biotech company focuses on cellular signaling pathways regulating normal cell proliferation and differentiation.
- Eric Fischer: Co-Founder
About the Company
Jengu Therapeutics is a biotechnology company founded by Benjamin Neel in 2020. The company conducts research focuses on cellular signaling pathways regulating normal cell proliferation and differentiation, and how disruption of these pathways can cause human diseases, especially cancer.